20mM, tryptophan 50~g/L, methionine 20ug/L, Mg++ 2mM, Ca++ 0.7mM, Mn÷+ 50~M, Zn÷+ I~M, Fe 5~M, Thiamine 2uM.
At the end of the logarithmic growth phase cells were harvested by continuous centrifugation using a Sharpies centrifuge.
Extraction:
The cell paste obtained following centrifugtion was weighed and homogenized using a Manton Gaulin homogenizer. The homogenates were then extracted in 5-10 volumes (v/w) cold acid/ethanol (0.2N HC1/75% ethanol) as previously described 1,2,6).
After overnight mixing at 4°C, this extract was centrifuged; the remaining supernatant concentrated by evaporation of the ethanol under nitrogen and then neutralized using 1.0N NaOH. The extact was boiled for 20 minutes, centrifuged, and trifluoroacetic acid (TFA) added to the remaining supernatant to a final concentration of 0.2%TFA. Unconditioned as well as conditioned medium from batches 2,3 and 5 were acidified using acetic acid and processed as for cells.
Sep~Pak C18 Purification: Celis and medium were applied to SepPak C18 (reverse phase) disposable I ml cartridges; one cartridge per 10 g. wet weight of cells and one cartridge per 100 ml. of medium. Elution of the material that adsorbed to the Sep~Pak column was performed using acetonirile in 0.1% TFA. The material that eluted with 25-50% acetonitrile was kept for further purification.
Biogel P-6 Chromatography: Further purification of the SRIF-LI eluting from the Sep-pak C18 columns was performed by Biogel P-6 column chromatography.
Samples were applied and eluted in 0.01% formic acid; individual fractions were lyophilized extensively and tested for SRIF-LI (6).
High Performance Liquid Chromatography (HPLC):
Fractions from the Biogel columns that contained SRIF~LI were combined and further purified by reverse phase HPLC using C18 ~Bondapak (Waters Association) at a flow rate of 1.0 ml per minute using isocratfc elution with 28% acetonitrile in O.01%TFA (6) .
Radioimmunoassay: At each step of the purification process, SRIF-LI material was measured by a C-terminal specific immunoassay as previously described (4, 6) . Limits of detectability were reproducibly I-2 pg per assay tube with 50% displacement of 10-15 pg per tube (6) . Following HPLC purification SRIF-LI as also measured by a N-terminal specific immunoassay as described (6) . Lower imit of detectability in this assay was 40 pg per assay tube and 50% displace ~ Lent was 200 pg per tube.
~omatostatin Bioassay: HPLC purified SRIF-LI was tested for biological Lctivity in an established bioassay for somatostatin (7) . Briefly, the effect ~f somatostatin on guinea pig oxyntic cell hydroxyl ion production is measured ~y quantitative cytochemistry. were applied to a 48 ml column (52cm x 0.gcm) and eluted with 0.01% formic acid. Individual 1.5 ml fractions were lyophilized, reconstituted in distilled water and tested for SRIF-LI using the C~terminal specific SRIF assay. SRIF-28 and SRIF-14 standards were run ~eparately (after the samples) under similar conditions. The arrows represent peak elution fractions for the synthetic standard preparations. Unconditioned medium had no detectable SRIF-LI, whereas conditioned medium had 80~380 pg/liter (Table I) .
HPLC Purification: SRIF-LI resolved into two major peaks on HPLC using an isocratic elution with 28% acetonitrile in 0.01% TFA (Figure 2) . The early peak eluted with a retention time similar to SRIF-28 and was immunoactive in both the C-terminal as well as the N-terminal specfic immunoassays.
The later peak eluted with a retention time similar to SRIF-14 and was only reactive in the C-terminal specific immunoassay ( Figure 2 ). Recoveries of SRIF-LI from columns were 85-95% and blank runs before and after application of the samples contained no detectable SRIF-LI.
Bioactivity: Synthetic SRIF~14 stimulated hydroxyl ion production by guinea pig gastric oxyntic cells in a dose dependent manner from .05 to 50 pg/ml. Serial dilutions of HPLC purified material from Bacillus also stimulated hydroxyl ion production ( Figure 3 ). Both the early HPLC peak ("SRIF-28", figure 2) as well as the later peak ("SRIF-14") demonstrated reasonably parallel biological activity which was similar to that of the synthetic somatostatin-14 standard preparation.
In addition the biological activity of each sample was inhibited almost completely by the presence of (C-terminal specific) anti~somatostatin antiserum ( Figure 3 ).
DISCUSSION
Originally isolated from extracts of mammalian hypothalamus, SRIF is found widespread throughout vertebrate tissues and more recently in The allquots were applied to a ~Bondapak reverse phase column. Solvent A contained 0.01% TFA and solvent B contained 98% acetonltrile in 0.01% TFA. Flow rate was 1.0 ml per minute.
Initial elution was carried out for 40 min under isocratic conditions using 28% acetonltrile and then the gradient was increased to 80% acetonitrile.
Fractions were collected, lyophilized, reconstituted in water and assayed for SRIF-LI using the C-terminal (upper panel) as well as the N~terminal assay (lower panel).
SRIF-28 and SRIF-14 standards were run separately and blank runs were devoid of SRIF-LI.
invertebrates (8, 9, 10) .
We have reported its presence in the unicellular protozoan Tetrahymena pyriformis and more recently in Escherichia coli (4, 6) . The presence in Bacillis subtilis of material closely resembling somatostatin adds support to the concept that somatostatin-like substances may be widespread among unicellular eukaryotes and prokaryotes.
The SRIF-LI immunoactivity recovered from the B. subtilis resolved into two peaks on HPLC, resembling SRIF-28 and SRIF-14. Both peaks were bioactive in a typical somatostatin bioassay which is characteristic of vertebrate 1:10,500 1:1500 1:100 1:10 EXTRACT Figure 3 .Hydroxyl ion production by guinea pig oxyntic cells was measured as the intensity of staining with cobalt sulfide detected by mlcrodensitometry and is presented as the mean integrated extinction times 100 as an index of this activity. Synthetic somatostatln -14 (0-0) was used as the standard and ([3{3) represents the early HPLC peak ("SRIF-28-11ke") whereas (~-~) represents the late HPLC peak ("SRIF-14-11ke.) from figure 2.
SRIF-28 and SRIF-14 (11, 12) . It is interesting to speculate that a precursor-product relationship similar to that in vertebrate species may be present in B. subtilis. However such a relationship has not been demonstrated by the present studies.
Quantities of SRIF-LI in Bacillus cells ranged widely probably reflecting marked variations in recoveries of endogenous SRIF-LI during multiple purification procedures. Alternatively SRIF-LI production may vary with growth conditions, which were not optimized in our cultures.
Contamination of the extracts by exogenously added SRIF-LI was excluded by the absence of SRIF-LI in unconditioned medium processed in an identical manner.
In addition blank runs were devoid of SRIF-LI and recoveries from chromatography columns were always slightly less than 100%.
It is apparent that the SRIF-LI identified by molecular sieve chromatography contained material with MW similar to somatostatin -28 and somatostatin -14. However, there was also significant immunoactive somatostatin eluting in other regions which may represent other molecular species of somatostation (13) .
Final confirmation of these findings will require isolation and sequencing of the gene(s) coding for SRIF in the prokaryotes.
